DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tolbutamide (Tolbutamide) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Tolbutamide and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (5)

Reports by Reaction Type

Hyperkalaemia (2)Hypoglycaemia (2)Blood Uric Acid Increased (2)Azotaemia (2)Hypertriglyceridaemia (2)Renal Impairment (2)Hypertension (2)Abdominal Pain (1)Blood Bilirubin Increased (1)Liver Injury (1)Pain (1)Pruritus Generalised (1)

Possible Tolbutamide side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-11

Patient: female

Reactions: Muscle Swelling, Pain, Psoriasis, Rash, Skin Tightness, Abdominal Pain Upper, Pruritus Generalised, Myalgia, Breath Sounds Abnormal, Eye Swelling, Dizziness, Eye Pruritus, Eustachian Tube Dysfunction

Drug(s) suspected as cause:
K-TAB
    Indication: Blood Potassium Decreased

Tolbutamide
    Indication: Hypertension

K-TAB
    Indication: Prophylaxis

Other drugs received by patient: Enbrel; Centrum; Levothroid



Possible Tolbutamide side effects in male

Reported by a physician from Japan on 2012-04-06

Patient: male

Reactions: Blood Bilirubin Increased, Hyperkalaemia, Nausea, Hypoglycaemia, Renal Impairment, Blood Uric Acid Increased, Drug Specific Antibody Present, Hypertension, Azotaemia, Hypertriglyceridaemia

Drug(s) suspected as cause:
Actemra
    Indication: Castleman's Disease
    Start date: 2008-10-31
    End date: 2009-03-06

Actemra
    Start date: 2010-01-14
    End date: 2010-12-02

Actemra
    Start date: 2011-01-07
    End date: 2011-02-04

Tolbutamide
    Administration route: Oral
    Indication: Diabetes Mellitus

Actemra
    Start date: 2009-03-19
    End date: 2010-01-04

Other drugs received by patient: Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pursennid; Espo; Prednisolone; Prednisolone; Prednisolone; Lansoprazole; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Allopurinol; Goodmin; Promacta; Benidipine Hydrochloride; Bisolvon; Marzulene-S; Prednisolone; Prednisolone; Prednisolone; Persantin; Lendormin; Losartan Potassium; Nespo; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pranlukast; Rebamipide; Myonal; Olopatadine HCL; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Pursennid; Singulair; Theolong; Prednisolone; Prednisolone; Prednisolone; Alfarol; Omeprazole; Neomallermin-TR; Kayexalate; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Advair Diskus 100 / 50; Nespo



Possible Tolbutamide side effects in male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-02-23

Patient: male, weighing 63.0 kg (138.6 pounds)

Reactions: Abdominal Discomfort, Abdominal Pain, Dyspnoea, Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tolbutamide
    Dosage: unk ukn, unk
    Indication: Diabetes Mellitus
    Start date: 2004-01-01

Metformin HCL
    Dosage: unk ukn, unk
    Indication: Diabetes Mellitus
    Start date: 2004-01-01

Other drugs received by patient: Pravastatin



Possible Tolbutamide side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-01-05

Patient: 52 year old female

Reactions: Liver Injury

Drug(s) suspected as cause:
Fluvastatin

Carbamazepine

Metformin HCL
    Indication: Type 2 Diabetes Mellitus

Enalapril Maleate
    Indication: Hypertension

Fluoxetine HCL

Tolbutamide



Possible Tolbutamide side effects in male

Reported by a physician from Japan on 2011-10-17

Patient: male

Reactions: Hyperkalaemia, Hypoglycaemia, Renal Impairment, Blood Uric Acid Increased, Hypertension, Azotaemia, Antibody Test Positive, Hypertriglyceridaemia

Drug(s) suspected as cause:
Actemra
    Start date: 2010-01-14
    End date: 2010-12-02

Actemra
    Start date: 2011-01-07
    End date: 2011-02-04

Actemra
    Start date: 2009-03-19
    End date: 2010-01-04

Tolbutamide
    Administration route: Oral
    Indication: Diabetes Mellitus

Actemra
    Indication: Castleman's Disease
    Start date: 2008-10-31
    End date: 2009-03-06

Other drugs received by patient: Espo; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Allopurinol; Pursennid; Lendormin; Pranlukast; Theolong; Rebamipide; Prednisolone; Prednisolone; Prednisolone; Singulair; Promac; Myonal; Olopatadine HCL; Nespo; Prednisolone; Prednisolone; Prednisolone; Omeprazole; Neomallermin-TR; Nespo; Persantin; Alfarol; Goodmin; Prednisolone; Prednisolone; Prednisolone; Pursennid; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Lansoprazole; Losartan Potassium; Marzulene-S; Kayexalate; Adoair; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Benidipine Hydrochloride; Bisolvon

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014